2 enrolling by invitation. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Enrolling by invitation 2 |
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation Anti Xa dosage, Dosage of PT-INR - Non Valvular Atrial Fibrillation | Phase 4 | Enrolling by invitation | Les Laboratoires des Médicaments Stériles | 120 | 2024-12-01 | 2025-03-06 |
| LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe - Sarcoma, Soft Tissue Sarcoma | Phase 4 | Enrolling by invitation | Massachusetts General Hospital | 2868 | 2018-02-16 | 2026-10-09 |
Bone Neoplasms (1) · Hematoma (1) · Hemorrhage (1) · Sarcoma (1) · Venous Thromboembolism (1)
Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Bone Diseases (1) · Hemorrhage (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Connective and Soft Tissue (1)
Aspirin (1) · Enoxaparin (1)
Les Laboratoires des Médicaments Stériles (1) · Massachusetts General Hospital (1)
Tunisia (1) · United States (1)
Santiago A Lozano-Calderon, MD, PhD (1)